Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Liver Cancer treatment details. Biologic therapy. UniversitÓ Cattolica del Sacro Cuore, Rome, Italy

Survival: 5.8 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: Italy
City/State/Province: Rome
Hospital: UniversitÓ Cattolica del Sacro Cuore
Journal: Link
Date: 2/2013

This phase 2 study involved 34 advanced hepatocellular carcinoma patients who had not been previously treated. The median patient age was 68 years and 91.2% were male.

Patients were treated with the biologic therapy agent sunitinib, which is a tyrosine kinase inhibitor that interferes with cancer cell growth.

There were six treatment-related deaths reported, the causes of which included cirrhosis and liver failure that may not have been related to liver cancer. Grade 4 gastrointestinal bleeding and thrombocytopenia, as well as grade 3 fatigue were also reported.

The median overall survival was 5.8 months.

This study was partially supported by Pfizer.

Correspondence: Dr. Carlo Barone; email:

E-mail to a Friend Email Physician More Information